An example on research is the Acoustic CADScore, which is a method for diagnosis of coronary artery disease based on advanced signal processing of heart sounds. Together with Samuel’s co-student Claus Graff he started the research as a master student, this leads to a Ph.D. project and later to a 2 million euro grant from Coloplast A/S and The Danish National Advanced Technology Foundation.
In 2009 the research and collaboration with Coloplast A/S resulted in the establishment of the spin-off company Acarix A/S, headed by Peter Samuelsen and Claus Bo Vöge Christensen. Acarix has raised double-digit million euros in venture capital and went public in December 2016. Now the Acoustic CADScor device is CE approved and sales started in late spring 2017.
See more at www.acarix.com